These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16471323

  • 1. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
    Di GH, Lu JS, Song CG, Li HC, Shen ZZ, Shao ZM.
    J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
    [Abstract] [Full Text] [Related]

  • 2. [Clinicopathological significance of aromatase expression in breast cancers].
    Lu JS, Li HC, Cao DC, Di GH, Wu J, Shen KW, Shen ZZ, Shao ZM.
    Zhonghua Wai Ke Za Zhi; 2006 Oct 01; 44(19):1318-21. PubMed ID: 17217816
    [Abstract] [Full Text] [Related]

  • 3. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.
    Breast Cancer Res Treat; 2006 Sep 01; 99(2):155-62. PubMed ID: 16541304
    [Abstract] [Full Text] [Related]

  • 4. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT.
    Acta Oncol; 2009 Sep 01; 48(4):522-31. PubMed ID: 19173092
    [Abstract] [Full Text] [Related]

  • 5. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology.
    Sasano H, Miki Y, Nagasaki S, Suzuki T.
    Pathol Int; 2009 Nov 01; 59(11):777-89. PubMed ID: 19883428
    [Abstract] [Full Text] [Related]

  • 6. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y, Kulp SK, Sugimoto Y, Farrar WB, Brueggemeier RW, Lin YC.
    Anticancer Res; 1998 Nov 01; 18(4A):2541-6. PubMed ID: 9703907
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 8. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y, Takei H, Suemasu K, Kobayashi Y, Kurosumi M, Harada N, Hayashi S.
    Cancer Res; 2005 Jun 01; 65(11):4653-62. PubMed ID: 15930283
    [Abstract] [Full Text] [Related]

  • 9. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K, Lykkesfeldt AE.
    J Steroid Biochem Mol Biol; 2005 Jan 01; 93(1):25-34. PubMed ID: 15748829
    [Abstract] [Full Text] [Related]

  • 10. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun 01; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 11. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H.
    Cancer Res; 2007 Apr 15; 67(8):3945-54. PubMed ID: 17440110
    [Abstract] [Full Text] [Related]

  • 12. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H.
    C R Seances Soc Biol Fil; 1998 Apr 15; 192(2):241-51. PubMed ID: 9841098
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.
    Breast Cancer Res Treat; 2006 Oct 15; 99(3):275-88. PubMed ID: 16752221
    [Abstract] [Full Text] [Related]

  • 14. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 15; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 15. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR, Chetrite GS.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):221-36. PubMed ID: 15860265
    [Abstract] [Full Text] [Related]

  • 16. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R.
    Clin Cancer Res; 2004 Nov 01; 10(21):7335-46. PubMed ID: 15534110
    [Abstract] [Full Text] [Related]

  • 17. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer.
    Walker G, MacLeod K, Williams AR, Cameron DA, Smyth JF, Langdon SP.
    Gynecol Oncol; 2007 Sep 01; 106(3):461-8. PubMed ID: 17624412
    [Abstract] [Full Text] [Related]

  • 18. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
    Kim HJ, Cui X, Hilsenbeck SG, Lee AV.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118
    [Abstract] [Full Text] [Related]

  • 19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 01; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 20. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
    Licznerska BE, Wegman PP, Nordenskjöld B, Wingren S.
    Breast Cancer Res Treat; 2008 Nov 01; 112(1):15-23. PubMed ID: 18030614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.